1. Home
  2. CMND vs IDAI Comparison

CMND vs IDAI Comparison

Compare CMND & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMND
  • IDAI
  • Stock Information
  • Founded
  • CMND 2017
  • IDAI 2016
  • Country
  • CMND Canada
  • IDAI United States
  • Employees
  • CMND N/A
  • IDAI N/A
  • Industry
  • CMND Biotechnology: Pharmaceutical Preparations
  • IDAI Computer Software: Prepackaged Software
  • Sector
  • CMND Health Care
  • IDAI Technology
  • Exchange
  • CMND Nasdaq
  • IDAI Nasdaq
  • Market Cap
  • CMND 6.0M
  • IDAI 5.5M
  • IPO Year
  • CMND N/A
  • IDAI N/A
  • Fundamental
  • Price
  • CMND $1.03
  • IDAI $1.88
  • Analyst Decision
  • CMND
  • IDAI
  • Analyst Count
  • CMND 0
  • IDAI 0
  • Target Price
  • CMND N/A
  • IDAI N/A
  • AVG Volume (30 Days)
  • CMND 55.0K
  • IDAI 73.9K
  • Earning Date
  • CMND 03-13-2025
  • IDAI 05-13-2025
  • Dividend Yield
  • CMND N/A
  • IDAI N/A
  • EPS Growth
  • CMND N/A
  • IDAI N/A
  • EPS
  • CMND N/A
  • IDAI N/A
  • Revenue
  • CMND N/A
  • IDAI $3,082,348.00
  • Revenue This Year
  • CMND N/A
  • IDAI $66.11
  • Revenue Next Year
  • CMND N/A
  • IDAI N/A
  • P/E Ratio
  • CMND N/A
  • IDAI N/A
  • Revenue Growth
  • CMND N/A
  • IDAI N/A
  • 52 Week Low
  • CMND $0.95
  • IDAI $0.15
  • 52 Week High
  • CMND $2.30
  • IDAI $8.96
  • Technical
  • Relative Strength Index (RSI)
  • CMND 34.60
  • IDAI 38.52
  • Support Level
  • CMND $1.04
  • IDAI $1.73
  • Resistance Level
  • CMND $1.11
  • IDAI $2.16
  • Average True Range (ATR)
  • CMND 0.06
  • IDAI 0.26
  • MACD
  • CMND -0.00
  • IDAI 0.01
  • Stochastic Oscillator
  • CMND 10.07
  • IDAI 17.31

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility.

Share on Social Networks: